期刊文献+

4例吡嘧司特钾临床不良反应分析 被引量:4

Analysis of Adverse Effects Associated with an Asthma Drug Pemirolast Potassium Tablets
下载PDF
导出
摘要 本文通过对4例吡嘧司特钾临床不良反应分析,简述其抗变态反应药不良反应与合理应用的相关性。 This paper describes the relationship between the adverse drug effects of anti-allergic drugs and their rational uses based on the analysis of clinical adverse reactions of asthma drug pemirolast potassium tablets.
出处 《药学与临床研究》 2011年第4期362-363,共2页 Pharmaceutical and Clinical Research
关键词 吡嘧司特钾片 不良反应 合理用药 Pemirolast potassium tablets Adverse effects Rational drug usages
  • 相关文献

参考文献3

二级参考文献18

  • 1蒋萍,闫玉兰,张宏誉.点刺皮肤试验的组胺阳性对照及临床意义[J].中华微生物学和免疫学杂志,2001,21(S2):84-86. 被引量:11
  • 2李薇,张尊建,田媛,沈建平,张银娣.LC-MS法测定人血浆中吡嘧司特钾浓度及药代动力学[J].中国药科大学学报,2005,36(1):48-51. 被引量:2
  • 3徐勤娥,林子萍,李泽卿,余盈盈,马未央,岳志勇,史丽,薛卫国,赵俊,柴怡,于浩,张银娣,沈建平.两种剂量的吡嘧司特钾片临床研究报告[J].中国临床药理学与治疗学,2007,12(4):465-469. 被引量:8
  • 4KAZUHISA M, MARIA ALEJANDRA H, CHIAKI K. Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats [ J ]. Biol Pharm Bull, 2005,28 (3) :473 - 476.
  • 5ISHIDA S, FUJIOKA M. Pemirolast potassium [ J ]. Drugs Fut, 1990,15(12) :1184 - 1190.
  • 6NAKAMURA Y,NAKASHIMA S, FUJIMIYA H,et al. Effects of an antiallergic drug,pemirolast potassium on tyrosine phosphorylation and map kinase activation in antigen-stimulated rat basophilic leukemia ( RBL-2H3 ) cells [ J]. Arerugi, 1995,44( 1 ) :34 -44.
  • 7YANAGIHARA Y,KASAI H,KAWASHIMA T,et al. Immunopharmacological studies on TBX, a new antiallergic drug. ( 1 ) Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs [J]. Jpn J Pharmacol,1988,48(1) :91 - 101.
  • 8YANAGIHARA Y,KASAI H,SHIDA T. lmmunopharmaeologieal studies on TBX,a new antiallergic drug. (2) Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats [J]. Jpn J Pharmacol,1988,48(1) :103 - 112.
  • 9YANAGIHARA Y, KASAI H, KAWASHIMA T, et al. Immunopharmacological studies on TBX,a new antiallergic drug (4). Effects on type Ⅱ to Ⅳ allergic reactions and immunological functions in animal models [ J ]. Jpn J Pharmacol, 1989,51 ( 1 ) :93 - 100.
  • 10MIYAKE-KASHIMA M,TAKANO Y,TANAKA M,et al. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis[ J]. Jpn J Ophthalmol,2004,48 ( 6 ) : 587 - 590.

共引文献17

同被引文献23

  • 1仕丽,李晓红,王檀,于秀华,张丽秀.定喘止哮颗粒对支气管哮喘动物模型血清IFN-γ、IL-4、IL-5的影响[J].中国老年学杂志,2014,34(12):3394-3395. 被引量:7
  • 2徐道华.第三代抗组胺药地氯雷他定[J].中国新药杂志,2005,14(12):1486-1488. 被引量:59
  • 3靳婷.氯雷他定可致严重药物不良反应——心脏毒性[J].首都医药,2006,13(23):31-31. 被引量:7
  • 4徐勤娥,林子萍,李泽卿,余盈盈,马未央,岳志勇,史丽,薛卫国,赵俊,柴怡,于浩,张银娣,沈建平.两种剂量的吡嘧司特钾片临床研究报告[J].中国临床药理学与治疗学,2007,12(4):465-469. 被引量:8
  • 5殷凯生,周建英,孙耕耘.吡嘧司特钾片与曲尼司特片治疗支气管哮喘和过敏性鼻炎安全性有效性的随机双模拟双盲、多中心平行对照临床研究//中华医学会第五次全国哮喘学术会议暨中国哮喘联盟第一次大会论文汇编,长沙,2006.
  • 6Jin H, Luo Q, Zheng Y, et al. CD4+CD25+Foxp3+ T cells contrib.ute to the antiasthmatic effects of Astragalus membranaceus extract ina rat model of asthma[J]. Int Immunopharmacol,2013,15(1):42-49.
  • 7Ricciardolo FLM, Sorbello V, Silvestri M, et al. TNF.α, IL.4Rαand IL.4 polymorphisms in mild to severe asthma from Italian Cauca.sians[J]. Int J Immunopathol Pharmacol, 2013, 26(1):75-84.
  • 8Imaoka H, Takenaka S, Kawayama T, et al. Increased serum levelsof soluble IL.18 receptor complex in patients with allergic asthma[J].Allergol Int, 2013, 62(4):513-515.
  • 9Yao X, Zha W, Song W. et al. Coordinated regulation of IL.4 andIL.13 expression in human t cells: 3c analysis for dna looping[J].Biochem Biophys Res Commun, 2012, 417(3):996-1001.
  • 10Rachmiel M, Bloch O, Shaul AA, et al. Young patients with bothtype 1 diabetes mellitus and asthma have a unique IL.12 and IL.18secretory pattern[J]. Pediatr Diabetes, 2011, 12(7):596-603.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部